CARLSBAD, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Aptera Motors (Nasdaq: SEV) announced today that Co-CEO Chris Anthony will participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference on December 9, 2025. The event is hosted by A.G.P./Alliance Global Partners. A.G.P.’s Capital Markets team works closely with portfolio managers of hedge funds, mutual funds, and registered investment advisors. Chris Anthony will deliver an investor presentation as part of the conference program. ...

Core Points - Copenhagen Airports A/S has received a notice from the Kingdom of Denmark regarding the mandatory tender offer [1] - The offer period for the mandatory tender offer will expire on 10 December 2025 at 11:59 p.m. (CET) [1] Company Announcement - The announcement serves as a reminder to shareholders about the expiry of the offer period for the mandatory tender offer [2] - The notice is issued via the Ministry of Finance of the Kingdom of Denmark [1][2]

Core Insights - Gelteq Limited has announced preclinical findings that demonstrate the effectiveness, flexibility, and safety of its proprietary gel-based oral delivery systems, addressing significant challenges in pharmaceutical development [1][6]. Preclinical Study Results - Two preclinical studies showed a 300% increase in bioavailability of an oil-soluble compound in Gelteq's gel base compared to an existing FDA-approved reference product within the first hour, which is critical for rapid onset of action [2]. - Overall absorption of the oil-soluble compound improved by more than 20% over 24 hours when using Gelteq's gel base compared to the reference product [3]. - The gel platform enables controlled movement through the digestive system, targeted release, and effective absorption while ensuring full clearance of both the active pharmaceutical ingredients and the gel material [4]. Mechanism of Action - The gel disperses the active ingredient uniformly along the small intestine, enhancing absorption through mucoadhesive interactions and presenting the drug across a larger intestinal surface area [5]. - The gel's structural matrix allows for efficient transit and rapid early absorption of the active pharmaceutical ingredient, reinforcing its safety and compatibility with oral administration [6]. Industry Context - Over 40% of approved drugs and up to 90% of developmental candidates face issues with poor solubility and bioavailability, leading to significant annual investments in new technologies to address these challenges [7]. - Gelteq's platform offers a streamlined solution that may reduce developmental burdens, enhance bioavailability, and potentially revive previously shelved or challenging molecules [7]. Therapeutic Applications - Therapeutic areas likely to benefit from Gelteq's gel-based delivery system include neurology, inflammation and pain management, hormonal therapies, cardiovascular medicine, nutraceuticals, weight management, oncology, and veterinary health, where lipid-based or poorly soluble APIs are common [8]. Strategic Positioning - By enabling consistent absorption, targeted delivery, reduced reliance on excipients, and strong safety characteristics, Gelteq positions itself as a valuable development partner for pharmaceutical and nutraceutical companies looking to reformulate existing assets or tackle complex formulation challenges [9].

Core Insights - Dangbei is offering significant discounts on its 4K home cinema and portable projectors during a limited-time promotion on Amazon.com, with savings of up to 47.4% and as much as $900 off selected models [3][12]. Product Offerings - The Dangbei DBOX02, a flagship 4K ALPD laser projector, is now priced at $999, down from $1,899, providing a 47.4% discount [6][7]. - The DBOX02 Pro, featuring a flexible gimbal stand, is available for $899, a 43.8% reduction from its original price of $1,599 [8]. - The MP1 Max, a 4K Hybrid Tri-Laser + LED projector, is now $1,399, reflecting a 30.0% discount from $1,999 [9]. - The Dangbei Atom, an ultra-slim laser projector, is priced at $549, down 38.9% from $899 [10]. - The portable Freedo projector is available for $349, a 36.4% discount from $549 [11]. - The compact N2 mini projector is now $149, down from $229, offering a 34.9% discount [12]. Promotional Period - The promotional offers are exclusively available on the Dangbei Store on Amazon.com from December 2 to December 15, 2025, targeting consumers looking for affordable home entertainment solutions during the holiday season [12]. Company Overview - Dangbei is recognized as a premium provider of smart entertainment solutions, specializing in home and portable projectors, with over 200 million users globally [13].

DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 30 NOVEMBRE 2025 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social237 553 695Nombre de droits de vote théoriques287 011 643Nombre de droits de vote exerçables282 190 807 Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTS AS O ...

Core Insights - AGCO Corporation, a leader in agricultural machinery, awarded the Prescott Frontier Days Rodeo Committee with a Massey Ferguson tractor as part of its Sowing Good Deeds™ contest, recognizing their community contributions [1][4] Company Overview - AGCO Corporation specializes in the design, manufacture, and distribution of agricultural machinery and precision ag technology, with net sales of approximately $11.7 billion in 2024 [6] Community Impact - The Prescott Frontier Days Rodeo Committee has significantly impacted over 30 community organizations and nonprofits in 2024 through donations and support, including youth programs, veteran organizations, food banks, and local schools [2] - The committee also organizes events that promote western heritage and community service, such as the Heritage Parade and Cowboy Church [3] Award Significance - The Sowing Good Deeds award aims to recognize rodeo committees that excel in community involvement and volunteerism, with Prescott Frontier Days being the ninth organization to receive this honor [4][5]

Core Viewpoint - Junshi Biosciences announced the acceptance of the new drug application (NDA) for roconkibart injection, a treatment for moderate to severe plaque psoriasis, by the National Medical Products Administration (NMPA) in China [1][5]. Company Overview - Junshi Biosciences is an innovation-driven biopharmaceutical company founded in December 2012, focusing on the discovery, development, and commercialization of innovative therapeutics [8]. - The company has a diversified R&D pipeline with over 50 drug candidates across five therapeutic areas: cancer, autoimmune, metabolic, neurological, and infectious diseases [8]. - Junshi has achieved significant milestones, including the approval of five products in China and international markets, notably toripalimab, which is China's first domestically produced anti-PD-1 monoclonal antibody [8]. Product Details - Roconkibart (JS005) is a recombinant humanized anti-IL-17A monoclonal antibody designed to treat moderate to severe plaque psoriasis by targeting the inflammatory pathway associated with the disease [1][6]. - The NDA submission is based on a pivotal phase 3 clinical study involving 747 patients across 60 clinical sites in China, demonstrating significant efficacy and a favorable safety profile [3][4]. Clinical Study Insights - The phase 3 clinical study showed that treatment with roconkibart for 12 weeks resulted in significant improvements in the Psoriasis Area and Severity Index (PASI) scores and static Physician Global Assessment (sPGA) scores compared to the placebo group [4]. - The efficacy of roconkibart was maintained throughout a 52-week treatment period, indicating its potential as a long-term treatment option for patients [4]. Market Implications - The acceptance of the NDA is seen as a critical step in transitioning roconkibart from clinical research to real-world application, with expectations for early approval to enhance treatment options for patients in China [5]. - The company aims to collaborate closely with regulatory authorities to expedite the product's market approval process [5].

Nexus 7 Elements LLC formed to deploy CHIPS™ technology across ACRG’s nationwide critical minerals operationsRENO, Nev., Dec. 05, 2025 (GLOBE NEWSWIRE) -- American Clean Resources Group Inc. (OTC: ACRG), a critical minerals processing company, announced the formation of Nexus 7 Elements LLC, a joint venture with Energ4 Mining Company LLC to commercialize rare earth element and mineral recovery technology across ACRG’s processing hub network. “By combining our feedstock access and infrastructure with Energ4' ...

Core Points - Embassy Bancorp, Inc. has promoted Jeffrey Skumin to Chief Financial Officer (CFO) effective December 31, 2025, to guide the financial strategy and growth of the company and its subsidiary, Embassy Bank for the Lehigh Valley [1] - Mr. Skumin has been with Embassy since March 2020, serving as Executive Vice President of Finance, and has played a significant role in the company's financial management [2] - Prior to joining Embassy, Mr. Skumin had a 19-year career as a CPA, including serving as an audit partner and Chief Accounting Officer for a large regional bank, enhancing his banking industry experience [3][4] Company Overview - Embassy Bancorp, Inc. is a community bank with $1.7 billion in assets, operating since 2001 with 10 branches and a full suite of digital banking services [4] - As of June 2025, Embassy Bank ranks 4th in deposit market share in Lehigh and Northampton Counties and has received multiple accolades, including "Best Bank" from The Morning Call and Lehigh Valley Style, and a 5-star rating from Bauer Financial for strength and stability [5]

Core Insights - Sunrise New Energy Co., Ltd. has been granted a patent for a method to enhance the fast-charging performance of silicon-carbon composite anode materials, indicating a significant technological advancement in the field [1][2][3] Company Developments - The patented technology addresses critical challenges in silicon-carbon composite anode materials, such as interfacial instability and insufficient ion transport efficiency, thereby improving electrochemical performance under high-rate charging conditions [2][3] - The company plans to increase investment in advanced anode material research and accelerate the pilot-scale validation and industrialization of its innovative technologies, reinforcing its leadership in solid-state battery materials and fast-charging anode materials [4] Industry Context - Silicon-carbon materials are recognized as a key focus for the development of future solid-state battery anodes, and the patent strengthens the company's position in this critical area [3] - The advancements in this technology are expected to enhance the competitiveness of the company in fast-charging batteries, energy storage systems, and solid-state battery supply chains [3]